Exploring Biological Linkage Between Circadian Disruption and Cancer Progression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

236 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-11-10

Study Completion Date

2019-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to explore the possible association between the circadian disruption and cancer progression.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Circadian Rhythm on the Spread of Circulating Tumor Cells in Lung Cancer Patients

NCT05988970

Lung Cancer

COMPLETED NA

Sleep Disturbance in Lung Cancer Patients.

NCT00187980

Lung Cancer

UNKNOWN

Radiomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers

NCT01585545

Lung Cancer

ENROLLING_BY_INVITATION

Effect of Sleep Disorder on the Development of Lung Tumors

NCT05745506

Sleep Disorder, Lung Tumor

NOT_YET_RECRUITING

The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients

NCT03290001

Nasopharyngeal Carcinoma

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The biological markers that are assumed to bridge this association are measured and analyzed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Breast cancer

Diagnosed breast cancer patients who are getting chemotherapy for the first time.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 18-70
* Breast cancer patients who are getting chemotherapy for the first time in life
* Patients are either having stage 4 cancer or starting neoadjuvant chemotherapy.
* Patient have signed on the informed consent, and well understood the objective and procedure of this study

Exclusion Criteria

* Patients already have received chemotherapy
* Patient had another cancer (except thyroid cancer) within 5 years
* Patient with severe medical condition
* Patient had taken psychiatric medication more than 1 month in life
* Patient worked the night shift for more than 1 month in 6 months

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No